These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23257017)

  • 1. Health claim regulation of probiotics in the USA and the EU: is there a middle way?
    Hoffmann DE
    Benef Microbes; 2013 Mar; 4(1):109-15. PubMed ID: 23257017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why the European Food Safety Authority was right to reject health claims for probiotics.
    Katan MB
    Benef Microbes; 2012 Jun; 3(2):85-9. PubMed ID: 22683835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yoghurt and probiotic bacteria in dietary guidelines of the member states of the European Union.
    Smug LN; Salminen S; Sanders ME; Ebner S
    Benef Microbes; 2014 Mar; 5(1):61-6. PubMed ID: 24463208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotics: definition, sources, selection, and uses.
    Sanders ME
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S58-61; discussion S144-51. PubMed ID: 18181724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current marketplace for probiotics: a Japanese perspective.
    Amagase H
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S73-5; discussion S144-51. PubMed ID: 18181727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics for animal nutrition in the European Union. Regulation and safety assessment.
    Anadón A; Martínez-Larrañaga MR; Aranzazu Martínez M
    Regul Toxicol Pharmacol; 2006 Jun; 45(1):91-5. PubMed ID: 16563585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics in the United States.
    Vanderhoof JA; Young R
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S67-72; discussion S144-51. PubMed ID: 18181726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutraceuticals and botanicals: overview and perspectives.
    Nicoletti M
    Int J Food Sci Nutr; 2012 Mar; 63 Suppl 1():2-6. PubMed ID: 22360273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-benefit claims for probiotic products.
    Heimbach JT
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bringing a probiotic-containing functional food to the market: microbiological, product, regulatory and labeling issues.
    Sanders ME; Huis in't Veld J
    Antonie Van Leeuwenhoek; 1999; 76(1-4):293-315. PubMed ID: 10532385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: a European perspective.
    Saxelin M
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S76-9; discussion S144-51. PubMed ID: 18181728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health benefits and health claims of probiotics: bridging science and marketing.
    Rijkers GT; de Vos WM; Brummer RJ; Morelli L; Corthier G; Marteau P
    Br J Nutr; 2011 Nov; 106(9):1291-6. PubMed ID: 21861940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of nutrition and health claims in Europe.
    Verhagen H; Vos E; Francl S; Heinonen M; van Loveren H
    Arch Biochem Biophys; 2010 Sep; 501(1):6-15. PubMed ID: 20417175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutrition and health claims: the role of food composition data.
    Buttriss JL; Benelam B
    Eur J Clin Nutr; 2010 Nov; 64 Suppl 3():S8-13. PubMed ID: 21045856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Health and nutrition claims made on food: what future?].
    Laplace JP
    Bull Acad Natl Med; 2006 Nov; 190(8):1663-80; discussion 1680-2. PubMed ID: 17650751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P; da Silva MF; Pettman S
    Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European consumers and health claims: attitudes, understanding and purchasing behaviour.
    Wills JM; Storcksdieck genannt Bonsmann S; Kolka M; Grunert KG
    Proc Nutr Soc; 2012 May; 71(2):229-36. PubMed ID: 22385589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulating the safety of probiotics--the European approach.
    von Wright A
    Curr Pharm Des; 2005; 11(1):17-23. PubMed ID: 15638749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PASSCLAIM - Synthesis and review of existing processes.
    Richardson DP; Affertsholt T; Asp NG; Bruce A; Grossklaus R; Howlett J; Pannemans D; Ross R; Verhagen H; Viechtbauer V
    Eur J Nutr; 2003 Mar; 42 Suppl 1():I96-111. PubMed ID: 12664324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotic foods and drugs: impact of US regulatory status on design of clinical trials.
    Hibberd PL; Davidson L
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S137-40; discussion S144-51. PubMed ID: 18181720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.